<DOC>
	<DOCNO>NCT00833820</DOCNO>
	<brief_summary>The investigator ' preliminary study demonstrate repetitive transcranial magnetic stimulation ( rTMS ) brain may determine slight slow rate disease progression ALS patient ( Di Lazzaro et al 2004 , 2006 ) . The aim study investigate whether rTMS motor cortex perform long period time ( 12 month ) group patient ALS , pronounce beneficial effect . The investigator compare disease progression two group patient : first group patient treat real rTMS ( one week daily treatment every month ) second group patient treat sham ( placebo ) rTMS .</brief_summary>
	<brief_title>Repetitive Transcranial Magnetic Stimulation ( rTMS ) Amyotrophic Lateral Sclerosis</brief_title>
	<detailed_description>Eligible patient diagnosis definite ALS accord El Escorial revise criterion clear clinical upper low motor neuron sign . Twenty patient definite ALS enrol allocate treatment : 10 active 10 sham stimulation . Patients randomly allocate one investigator involve follow-up evaluation data analysis . Stratified block randomisation perform two treatment group evenly balance disease severity , evaluate revise ALS functional rating scale ( ALSFRS-R ) , duration . The patient neurologist assess outcomes blind group assignment . Outcome measure Patients evaluate begin treatment every month end study 1 year . At visit , patient evaluate use ALSFRS-R manual muscle test ( MMT ) . MMT test perform mean Medical Research Council ( MRC ) Scale . To obtain estimate overall limb muscle strength calculate MRC compound score add MRC score eight upper limb muscle five low limb muscle side divide sum number muscle test ( 26 muscle ) . We test follow muscle : biceps brachii , deltoid , triceps brachii , extensor carpus radialis , extensor digitorum communis , abductor digiti minimi , abductor pollicis brevis , opponens pollicis , iliopsoas , rectus femoris , tibialis anterior , extensor hallucis longus , gastrocnemius . The primary outcome measure rate decline ALSFRS-R score . Secondary outcome measure rate decline MMT . Transcranial brain stimulation Central motor conduction time first dorsal interosseous muscle calculate subtract peripheral conduction time , spinal cord muscle , latency response evoke cortical stimulation maximum stimulator output voluntary contraction 20 % maximum . Repetitive TMS apply hand motor area use MagPro ( Medtronic A/S Denmark ) stimulator figure eight-shaped coil . Active rTMS perform use cTBS pattern 3 pulse stimulation give 50Hz , repeat every 200 m total 600 pulse . We use butterfly coil ( MCF-B-65 ) handle point posteriorly approximately perpendicular central sulcus . The initial direction current induced brain posterior-anterior . The stimulation intensity 80 % active motor threshold ( AMT ) , define minimum single pulse intensity require produce motor evoke potential great 200 uV five ten trial contract contralateral first interosseous muscle . This protocol lead pronounce prolonged suppression cortical excitability reach maximum 5-10 min end stimulation . Sham rTMS perform use stimulator connect placebo butterfly coil MCF-P-B-65 stimulating effect cortex produce similar auditory tactile sensation active coil . The site stimulation number stimuli identical use active magnetic rTMS . Repetitive TMS perform bilaterally . The order stimulation two hemisphere randomize . The stimulation two hemisphere perform sequentially interval one minute . The motor cortex side stimulate five consecutive day every month twelve consecutive month . In patient absent first dorsal interosseous motor evoke potential stimulation one hemisphere , repetitive stimulation perform intensity use opposite hemisphere . Statistical analysis Statistical analysis perform use two-factor ( TIME TREATMENT ) repeat measure analysis variance .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>Eligible patient diagnosis definite ALS accord El Escorial revise criterion clear clinical upper low motor neuron sign . Contraindications transcranial magnetic stimulation : Tracheostomy Pacemaker Implanted metallic device Epilepsy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>ALS</keyword>
	<keyword>transcranial brain stimulation</keyword>
</DOC>